中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

80 records (took 0.023 seconds)

    INFUSION SYSTEMS AND RELATED PERSONALIZED BOLUSING METHODS
    51.
    发明申请
    INFUSION SYSTEMS AND RELATED PERSONALIZED BOLUSING METHODS 审中-公开

    公开(公告)号：US20200254175A1

    公开(公告)日：2020-08-13

    申请号：US16547512

    申请日：2019-08-21

    Applicant: MEDTRONIC MINIMED, INC.

    Inventor： Anirban Roy ,  Benyamin Grosman ,  Neha J. Parikh ,  Di Wu ,  Louis J. Lintereur

    IPC: A61M5/172 ,  A61M5/142 ,  G16H20/17

    Abstract: Infusion systems, infusion devices, and related operating methods are provided. A method of operating an infusion device involves obtaining an input qualitative event attribute, such as a meal size, obtaining a quantitative event attribute associated with the qualitative event attribute that is representative of a subset of historical events for a patient associated with the qualitative event attribute, such as a representative carbohydrate amount for the qualitative meal size, and thereafter determine a dosage of fluid based at least in part on the quantitative event attribute and operate the infusion device to deliver the dosage of the fluid to the patient.

    METHODOLOGY TO RECOMMEND AND IMPLEMENT ADJUSTMENTS TO A FLUID INFUSION DEVICE OF A MEDICATION DELIVERY SYSTEM
    52.
    发明申请
    METHODOLOGY TO RECOMMEND AND IMPLEMENT ADJUSTMENTS TO A FLUID INFUSION DEVICE OF A MEDICATION DELIVERY SYSTEM 审中-公开

    公开(公告)号：US20190321551A1

    公开(公告)日：2019-10-24

    申请号：US15960495

    申请日：2018-04-23

    Applicant: MEDTRONIC MINIMED, INC.

    Inventor： Neha J. Parikh ,  Anirban Roy ,  Benyamin Grosman ,  Patrick E. Weydt ,  Louis J. Lintereur ,  Di Wu ,  Francine R. Kaufman ,  Scott W. Lee

    IPC: A61M5/172

    Abstract: Disclosed here is a computer-based device and related methodology that manages use of a dual-mode insulin infusion device. The infusion device operates in a manual insulin delivery mode or an automated closed-loop insulin delivery mode. The methodology receives closed-loop pump data for a user of the infusion device, the closed-loop pump data including data indicating basal insulin delivered by the infusion device during operation in the automated closed-loop insulin delivery mode for at least one defined period of time. The methodology analyzes the closed-loop pump data to generate updated basal rate data for the user, and generates, from the updated basal rate data, a recommendation to adjust a manual-mode basal rate setting of the infusion device. In certain scenarios, the infusion device is controlled such that the manual-mode basal rate setting is adjusted in accordance with the recommendation.

    DEFAULT CARBOHYDRATE CONSUMPTION COUNTS BASED ON POPULATION CARBOHYDRATE CONSUMPTION MODELS
    57.
    发明申请
    DEFAULT CARBOHYDRATE CONSUMPTION COUNTS BASED ON POPULATION CARBOHYDRATE CONSUMPTION MODELS 有权

    公开(公告)号：US20210398639A1

    公开(公告)日：2021-12-23

    申请号：US17336912

    申请日：2021-06-02

    Applicant: Medtronic MiniMed, Inc.

    Inventor： Anirban Roy ,  Benyamin Grosman ,  Louis J. Lintereur ,  Peter Onesti ,  Di Wu ,  Neha J. Parikh

    IPC: G16H20/17 ,  G16H20/60 ,  G06N3/08 ,  A61M5/172

    Abstract: The present disclosure relates to default carbohydrate consumption counts based on population carbohydrate consumption models. Aspects of the present disclosure relate to receiving, from a device, at least one characteristic of a person; accessing a population carbohydrate consumption model which relates the at least one characteristic with carbohydrate intake for a population; determining, based on applying the population carbohydrate consumption model to the at least one characteristic, at least one of: a preliminary carbohydrate count for the person or a default carbohydrate consumption count for the person; and causing delivery of insulin to the person based on communicating, to the device, at least one of: the preliminary carbohydrate count for the person or the default carbohydrate consumption count for the person.

    Personalized closed loop medication delivery system that utilizes a digital twin of the patient
    58.
    发明授权
    Personalized closed loop medication delivery system that utilizes a digital twin of the patient 有权

    公开(公告)号：US11158413B2

    公开(公告)日：2021-10-26

    申请号：US16386104

    申请日：2019-04-16

    Applicant: MEDTRONIC MINIMED, INC.

    Inventor： Benyamin Grosman ,  Di Wu ,  Louis J. Lintereur ,  Anirban Roy ,  Neha J. Parikh ,  Patrick E. Weydt ,  Ali Dianaty

    IPC: G16H20/17 ,  A61M5/172 ,  A61B5/00 ,  A61M5/142

    Abstract: A medical device system and related method of automatically adjusting parameters of an insulin delivery controller of an insulin infusion device are disclosed. The methodology obtains therapy-related data associated with operation of the insulin infusion device for a number of days in the past, including sensor glucose data associated with glucose levels of the user, and meal data associated with identified meals. The obtained therapy-related data is processed to generate a suitable pharmacokinetic/pharmacodynamic (PK/PD) model of the user, wherein the PK/PD model fits at least some of the sensor glucose data obtained for the user. The PK/PD model can be used to calculate at least one adjusted parameter of the insulin delivery controller, based on additional therapy-related data associated with further operation of the insulin infusion device. The insulin delivery controller can be instructed or controlled to adjust its settings in accordance with the model-calculated parameters.

    Insulin infusion device with configurable target blood glucose value for automatic basal insulin delivery operation
    60.
    发明授权
    Insulin infusion device with configurable target blood glucose value for automatic basal insulin delivery operation 有权

    公开(公告)号：US11097052B2

    公开(公告)日：2021-08-24

    申请号：US16419401

    申请日：2019-05-22

    Applicant: MEDTRONIC MINIMED, INC.

    Inventor： Louis J. Lintereur ,  Benyamin Grosman ,  Anirban Roy ,  Neha J. Parikh ,  Di Wu

    IPC: A61M5/172

    Abstract: An insulin infusion device and related operating methods are disclosed. An operating method maintains a configurable, patient-specific, target glucose setpoint for a user of the insulin infusion device, collects historical data associated with operation of the insulin infusion device, and calculates, from the historical data, a target glucose setpoint profile for the user of the insulin infusion device. A current target glucose setpoint value is automatically adjusted over time during a closed-loop operating mode of the insulin infusion device, in accordance with the calculated target glucose setpoint profile. In certain embodiments, the historical data is analyzed to determine a clinically preferred target glucose setpoint value for the user, which is stored for use during the closed-loop operating mode.

Patent Agency Ranking